HEADER CELL CYCLE 26-JUN-06 2IW6 TITLE STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A COMPLEXED WITH A TITLE 2 BISANILINOPYRIMIDINE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: CELL DIVISION PROTEIN KINASE 2; COMPND 3 CHAIN: A, C; COMPND 4 SYNONYM: CYCLIN DEPENDENT KINASE 2, P33 PROTEIN KINASE; COMPND 5 EC: 2.7.1.37; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 OTHER_DETAILS: PHOSPHOTHREONINE 160; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: CYCLIN-A2; COMPND 11 CHAIN: B, D; COMPND 12 FRAGMENT: A3, RESIDUES 174-432; COMPND 13 SYNONYM: HUMAN CYCLIN A, CYCLIN-A; COMPND 14 ENGINEERED: YES; COMPND 15 OTHER_DETAILS: MONOTHIOGLYCEROL ADDUCT ON RESIDUE 193 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PGEX 6P-1; SOURCE 10 OTHER_DETAILS: WILD TYPE GENE WAS A GIFT FROM DR D.O.MORGAN; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 16 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 17 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 18 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 19 EXPRESSION_SYSTEM_PLASMID: PET21D; SOURCE 20 OTHER_DETAILS: FULL-LENGTH CYCLIN A WAS A GIFT FROM DR M.DOREE KEYWDS PHOSPHORYLATION, NUCLEOTIDE-BINDING, SERINE/THREONINE-PROTEIN KINASE, KEYWDS 2 CELL CYCLE COMPLEX, KINASE, MITOSIS, CELL CYCLE, TRANSFERASE, ATP- KEYWDS 3 BINDING EXPDTA X-RAY DIFFRACTION AUTHOR D.J.PRATT,J.BENTLEY,P.JEWSBURY,F.T.BOYLE,J.A.ENDICOTT,M.E.M.NOBLE REVDAT 6 13-NOV-24 2IW6 1 REMARK REVDAT 5 13-DEC-23 2IW6 1 REMARK LINK REVDAT 4 14-NOV-12 2IW6 1 REMARK DBREF MODRES REVDAT 3 13-JUL-11 2IW6 1 VERSN REVDAT 2 24-FEB-09 2IW6 1 VERSN REVDAT 1 06-SEP-06 2IW6 0 JRNL AUTH D.J.PRATT,J.BENTLEY,P.JEWSBURY,F.T.BOYLE,J.A.ENDICOTT, JRNL AUTH 2 M.E.M.NOBLE JRNL TITL DISSECTING THE DETERMINANTS OF CYCLIN-DEPENDENT KINASE 2 AND JRNL TITL 2 CYCLIN-DEPENDENT KINASE 4 INHIBITOR SELECTIVITY. JRNL REF J.MED.CHEM. V. 49 5470 2006 JRNL REFN ISSN 0022-2623 JRNL PMID 16942020 JRNL DOI 10.1021/JM060216X REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 100.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 93.1 REMARK 3 NUMBER OF REFLECTIONS : 58213 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.231 REMARK 3 R VALUE (WORKING SET) : 0.228 REMARK 3 FREE R VALUE : 0.287 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 3125 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.36 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3468 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.3070 REMARK 3 BIN FREE R VALUE SET COUNT : 174 REMARK 3 BIN FREE R VALUE : 0.3750 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 8869 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 79 REMARK 3 SOLVENT ATOMS : 114 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 36.46 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.46000 REMARK 3 B22 (A**2) : 1.85000 REMARK 3 B33 (A**2) : -0.03800 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.351 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.271 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.198 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 16.380 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.933 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.892 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 9171 ; 0.018 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 12450 ; 1.713 ; 1.986 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 1096 ; 6.754 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 391 ;40.480 ;23.913 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1599 ;19.004 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 44 ;16.771 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1404 ; 0.118 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 6806 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 4167 ; 0.209 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 6178 ; 0.302 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 314 ; 0.203 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 68 ; 0.200 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 5 ; 0.338 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 5675 ; 0.682 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 8966 ; 1.135 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 3989 ; 1.822 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 3484 ; 2.673 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 2 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : A C REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 0 A 298 4 REMARK 3 1 C 0 C 298 4 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 MEDIUM POSITIONAL 1 A (A): 2354 ; .40 ; .50 REMARK 3 MEDIUM THERMAL 1 A (A**2): 2354 ; .88 ; 2.00 REMARK 3 REMARK 3 NCS GROUP NUMBER : 2 REMARK 3 CHAIN NAMES : B D REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 B 175 B 432 4 REMARK 3 1 D 175 D 432 4 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 MEDIUM POSITIONAL 2 B (A): 2061 ; .33 ; .50 REMARK 3 MEDIUM THERMAL 2 B (A**2): 2061 ; .80 ; 2.00 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 4 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 0 A 298 REMARK 3 RESIDUE RANGE : A 1296 A 1296 REMARK 3 ORIGIN FOR THE GROUP (A): 6.6730 40.8610 64.5620 REMARK 3 T TENSOR REMARK 3 T11: -.2528 T22: -.1316 REMARK 3 T33: -.0408 T12: .0085 REMARK 3 T13: -.0255 T23: .0275 REMARK 3 L TENSOR REMARK 3 L11: 1.5647 L22: 1.3559 REMARK 3 L33: 1.5591 L12: .3925 REMARK 3 L13: -.7382 L23: -.3348 REMARK 3 S TENSOR REMARK 3 S11: .0383 S12: .0674 S13: -.0792 REMARK 3 S21: -.1797 S22: .0300 S23: .1152 REMARK 3 S31: -.0533 S32: -.1738 S33: -.0683 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 175 B 432 REMARK 3 ORIGIN FOR THE GROUP (A): 21.7870 67.7210 77.1050 REMARK 3 T TENSOR REMARK 3 T11: -.1760 T22: -.1497 REMARK 3 T33: -.0773 T12: .0014 REMARK 3 T13: .0254 T23: -.0312 REMARK 3 L TENSOR REMARK 3 L11: 1.3524 L22: 1.7019 REMARK 3 L33: 1.8393 L12: -.1986 REMARK 3 L13: .3721 L23: -.3458 REMARK 3 S TENSOR REMARK 3 S11: -.0828 S12: -.1860 S13: .1283 REMARK 3 S21: .0984 S22: .0917 S23: -.0664 REMARK 3 S31: -.2634 S32: -.0590 S33: -.0089 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : C 0 C 298 REMARK 3 RESIDUE RANGE : C 1296 C 1296 REMARK 3 ORIGIN FOR THE GROUP (A): 46.8725 80.6486 41.2530 REMARK 3 T TENSOR REMARK 3 T11: .0613 T22: .6213 REMARK 3 T33: -.0020 T12: -.2625 REMARK 3 T13: -.0466 T23: .1965 REMARK 3 L TENSOR REMARK 3 L11: 2.7060 L22: 1.8351 REMARK 3 L33: 2.6546 L12: .0813 REMARK 3 L13: .0851 L23: -.1809 REMARK 3 S TENSOR REMARK 3 S11: -.0280 S12: .6706 S13: .1905 REMARK 3 S21: .0361 S22: -.1452 S23: -.2188 REMARK 3 S31: -.4823 S32: 1.2051 S33: .1732 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : D 175 D 432 REMARK 3 ORIGIN FOR THE GROUP (A): 44.4280 47.5650 39.1940 REMARK 3 T TENSOR REMARK 3 T11: .1246 T22: .4739 REMARK 3 T33: .0993 T12: .3967 REMARK 3 T13: -.0146 T23: .0096 REMARK 3 L TENSOR REMARK 3 L11: 3.2354 L22: 2.8329 REMARK 3 L33: 2.5048 L12: .8198 REMARK 3 L13: .0875 L23: .1487 REMARK 3 S TENSOR REMARK 3 S11: .0161 S12: .1745 S13: -.5904 REMARK 3 S21: .2229 S22: -.0078 S23: -.6322 REMARK 3 S31: .6525 S32: 1.2016 S33: -.0084 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 2IW6 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 26-JUN-06. REMARK 100 THE DEPOSITION ID IS D_1290029196. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 31-AUG-03 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.00 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-3 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.931 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 61358 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 41.200 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.8 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : 0.10000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 5.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.41 REMARK 200 COMPLETENESS FOR SHELL (%) : 87.0 REMARK 200 DATA REDUNDANCY IN SHELL : 2.20 REMARK 200 R MERGE FOR SHELL (I) : 0.44000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1H1S REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.26 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.90 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: THE DROPLET CONTAINED PROTEIN AT A REMARK 280 CONCENTRATION OF 10 MG ML-1 IN 40 MM HEPES PH 7.0 CONTAINING 1 REMARK 280 MM DTT, 200 MM NACL, 5% V/V DMSO AND SATURATED INHIBITOR. THE REMARK 280 RESERVOIR SOLUTION CONTAINED 0.8 M KCL AND 1.2 M (NH4)2SO4 IN 40 REMARK 280 MM HEPES PH 7.0 AND 5 MM DTT., PH 7.00 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 36.88850 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 74.13250 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 67.27850 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 74.13250 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 36.88850 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 67.27850 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4310 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 22970 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -28.4 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4330 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 23320 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -20.4 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED RESIDUE IN CHAIN A, LYS 89 TO THR REMARK 400 ENGINEERED RESIDUE IN CHAIN C, LYS 89 TO THR REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -3 REMARK 465 PRO A -2 REMARK 465 GLY A -1 REMARK 465 ASP A 38 REMARK 465 THR A 39 REMARK 465 GLU A 40 REMARK 465 LEU A 296 REMARK 465 ARG A 297 REMARK 465 LEU A 298 REMARK 465 MET B 173 REMARK 465 GLU B 174 REMARK 465 VAL B 175 REMARK 465 GLY C -3 REMARK 465 PRO C -2 REMARK 465 GLY C -1 REMARK 465 LEU C 296 REMARK 465 ARG C 297 REMARK 465 LEU C 298 REMARK 465 MET D 173 REMARK 465 GLU D 174 REMARK 465 VAL D 175 REMARK 465 PRO D 176 REMARK 465 ASP D 177 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE2 GLU A 51 O HOH A 2006 1.88 REMARK 500 NE2 GLN B 317 O HOH B 2032 2.09 REMARK 500 OH TYR A 15 OE1 GLU A 51 2.12 REMARK 500 O GLN D 203 O HOH D 2002 2.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 THR D 368 CB THR D 368 OG1 0.128 REMARK 500 GLY D 369 C GLN D 370 N 0.144 REMARK 500 GLN D 370 CD GLN D 370 OE1 0.228 REMARK 500 GLU D 374 CD GLU D 374 OE2 0.105 REMARK 500 SER D 375 CB SER D 375 OG 0.252 REMARK 500 GLY D 381 C GLY D 381 O 0.104 REMARK 500 GLY D 381 C TYR D 382 N 0.153 REMARK 500 LYS D 414 CE LYS D 414 NZ 0.217 REMARK 500 GLY D 420 C GLY D 420 O 0.108 REMARK 500 GLY D 420 C VAL D 421 N 0.202 REMARK 500 VAL D 421 C VAL D 421 O 0.148 REMARK 500 VAL D 421 C SER D 422 N 0.190 REMARK 500 LEU D 423 C LEU D 423 O 0.260 REMARK 500 LEU D 423 C LEU D 424 N 0.167 REMARK 500 ASN D 425 CG ASN D 425 OD1 0.180 REMARK 500 ASN D 425 CG ASN D 425 ND2 0.215 REMARK 500 GLU D 428 CA GLU D 428 CB 0.143 REMARK 500 GLU D 428 CD GLU D 428 OE1 -0.078 REMARK 500 THR D 429 C LEU D 430 N 0.224 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 127 40.63 -155.28 REMARK 500 ASP A 145 77.16 52.44 REMARK 500 VAL A 164 120.48 81.92 REMARK 500 SER A 181 -148.90 -143.52 REMARK 500 ASP A 223 -167.98 -112.30 REMARK 500 ASP B 283 49.63 70.98 REMARK 500 ASP B 284 49.24 33.55 REMARK 500 TRP B 372 107.81 -23.72 REMARK 500 HIS B 419 29.56 44.95 REMARK 500 GLU C 8 149.87 -173.69 REMARK 500 GLU C 40 -25.80 60.57 REMARK 500 THR C 41 -84.61 -119.59 REMARK 500 THR C 97 -34.81 -138.84 REMARK 500 ASP C 127 47.10 -164.75 REMARK 500 ASP C 145 74.44 55.38 REMARK 500 TYR C 159 -164.56 -125.68 REMARK 500 VAL C 164 134.63 64.76 REMARK 500 LEU C 166 -72.37 -46.23 REMARK 500 TRP C 167 -30.52 -30.42 REMARK 500 SER C 181 -152.99 -162.98 REMARK 500 ARG C 199 -22.04 74.14 REMARK 500 SER C 207 153.54 178.41 REMARK 500 PRO C 254 3.65 -60.49 REMARK 500 TRP D 372 103.80 -19.37 REMARK 500 LEU D 424 164.06 -49.74 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 GLU D 428 15.91 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG B1434 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 MET B 200 O REMARK 620 2 GLN B 203 O 91.5 REMARK 620 3 ILE B 206 O 110.4 101.8 REMARK 620 N 1 2 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG B 1434 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE QQ2 A 1296 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE QQ2 C 1296 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SGM B 1433 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SGM D 1433 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1AQ1 RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR REMARK 900 STAUROSPORINE REMARK 900 RELATED ID: 1B38 RELATED DB: PDB REMARK 900 HUMAN CYCLIN-DEPENDENT KINASE 2 REMARK 900 RELATED ID: 1B39 RELATED DB: PDB REMARK 900 HUMAN CYCLIN-DEPENDENT KINASE 2 PHOSPHORYLATED ON THR 160 REMARK 900 RELATED ID: 1BUH RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN CDK2 KINASE COMPLEX WITHCELL CYCLE- REMARK 900 REGULATORY PROTEIN CKSHS1 REMARK 900 RELATED ID: 1CKP RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR REMARK 900 PURVALANOL B REMARK 900 RELATED ID: 1DI8 RELATED DB: PDB REMARK 900 THE STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 (CDK2) IN COMPLEX WITH 4- REMARK 900 [3- HYDROXYANILINO]-6,7-DIMETHOXYQUINAZOLINE REMARK 900 RELATED ID: 1DM2 RELATED DB: PDB REMARK 900 HUMAN CYCLIN-DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR REMARK 900 HYMENIALDISINE REMARK 900 RELATED ID: 1E1V RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR NU2058 REMARK 900 RELATED ID: 1E1X RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR NU6027 REMARK 900 RELATED ID: 1E9H RELATED DB: PDB REMARK 900 THR 160 PHOSPHORYLATED CDK2 - HUMAN CYCLIN A3 COMPLEX WITH THE REMARK 900 INHIBITOR INDIRUBIN-5- SULPHONATE BOUND REMARK 900 RELATED ID: 1F5Q RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MURINE GAMMA HERPESVIRUS CYCLIN COMPLEXED TO REMARK 900 HUMAN CYCLIN DEPENDANT KINASE 2 REMARK 900 RELATED ID: 1FIN RELATED DB: PDB REMARK 900 CYCLIN A - CYCLIN-DEPENDENT KINASE 2 COMPLEX REMARK 900 RELATED ID: 1FQ1 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF KINASE ASSOCIATED PHOSPHATASE (KAP) INCOMPLEX REMARK 900 WITH PHOSPHO-CDK2 REMARK 900 RELATED ID: 1FVT RELATED DB: PDB REMARK 900 THE STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 (CDK2) INCOMPLEX WITH AN REMARK 900 OXINDOLE INHIBITOR REMARK 900 RELATED ID: 1FVV RELATED DB: PDB REMARK 900 THE STRUCTURE OF CDK2/CYCLIN A IN COMPLEX WITH AN OXINDOLEINHIBITOR REMARK 900 RELATED ID: 1G5S RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2)IN REMARK 900 COMPLEX WITH THE INHIBITOR H717 REMARK 900 RELATED ID: 1GIH RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE CDK4INHIBITOR REMARK 900 RELATED ID: 1GII RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE CDK4INHIBITOR REMARK 900 RELATED ID: 1GIJ RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE CDK4INHIBITOR REMARK 900 RELATED ID: 1GY3 RELATED DB: PDB REMARK 900 PCDK2/CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE SUBSTRATE REMARK 900 RELATED ID: 1GZ8 RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR 2- REMARK 900 AMINO-6-(3'-METHYL- 2'-OXO)BUTOXYPURINE REMARK 900 RELATED ID: 1H00 RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH A DISUBSTITUTED 4, 6 -BIS ANILINO PYRIMIDINE REMARK 900 CDK4 INHIBITOR REMARK 900 RELATED ID: 1H01 RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH A DISUBSTITUTED 2, 4 -BIS ANILINO PYRIMIDINE REMARK 900 CDK4 INHIBITOR REMARK 900 RELATED ID: 1H07 RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH A DISUBSTITUTED 4, 6 -BIS ANILINO PYRIMIDINE REMARK 900 CDK4 INHIBITOR REMARK 900 RELATED ID: 1H08 RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH A DISUBSTITUTED 2, 4 -BIS ANILINO PYRIMIDINE REMARK 900 CDK4 INHIBITOR REMARK 900 RELATED ID: 1H0V RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT PROTEIN KINASE 2 IN COMPLEX WITH THE REMARK 900 INHIBITOR 2-AMINO-6-[(R )-PYRROLIDINO-5'-YL]METHOXYPURINE REMARK 900 RELATED ID: 1H0W RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT PROTEIN KINASE 2 IN COMPLEX WITH THE REMARK 900 INHIBITOR 2-AMINO-6-[ CYCLOHEX-3-ENYL]METHOXYPURINE REMARK 900 RELATED ID: 1H1P RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/ CYCLIN A COMPLEXED WITH THE REMARK 900 INHIBITOR NU2058 REMARK 900 RELATED ID: 1H1Q RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/ CYCLIN A COMPLEXED WITH THE REMARK 900 INHIBITOR NU6094 REMARK 900 RELATED ID: 1H1R RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/ CYCLIN A COMPLEXED WITH THE REMARK 900 INHIBITOR NU6086 REMARK 900 RELATED ID: 1H1S RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/ CYCLIN A COMPLEXED WITH THE REMARK 900 INHIBITOR NU6102 REMARK 900 RELATED ID: 1H24 RELATED DB: PDB REMARK 900 CDK2/CYCLINA IN COMPLEX WITH A 9 RESIDUE RECRUITMENT PEPTIDE FROM REMARK 900 E2F REMARK 900 RELATED ID: 1H25 RELATED DB: PDB REMARK 900 CDK2/CYCLINA IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM REMARK 900 E2F REMARK 900 RELATED ID: 1H26 RELATED DB: PDB REMARK 900 CDK2/CYCLINA IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM REMARK 900 P53 REMARK 900 RELATED ID: 1H27 RELATED DB: PDB REMARK 900 CDK2/CYCLINA IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM REMARK 900 P27 REMARK 900 RELATED ID: 1H28 RELATED DB: PDB REMARK 900 CDK2/CYCLINA IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM REMARK 900 P107 REMARK 900 RELATED ID: 1HCK RELATED DB: PDB REMARK 900 HUMAN CYCLIN-DEPENDENT KINASE 2 REMARK 900 RELATED ID: 1HCL RELATED DB: PDB REMARK 900 HUMAN CYCLIN-DEPENDENT KINASE 2 REMARK 900 RELATED ID: 1JST RELATED DB: PDB REMARK 900 PHOSPHORYLATED CYCLIN-DEPENDENT KINASE-2 BOUND TO CYCLIN A REMARK 900 RELATED ID: 1JSU RELATED DB: PDB REMARK 900 P27(KIP1)/CYCLIN A/CDK2 COMPLEX REMARK 900 RELATED ID: 1JSV RELATED DB: PDB REMARK 900 THE STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 (CDK2) INCOMPLEX WITH 4- REMARK 900 [(6-AMINO-4- PYRIMIDINYL)AMINO]BENZENESULFONAMIDE REMARK 900 RELATED ID: 1JVP RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CDK2 ( UNPHOSPHORYLATED) INCOMPLEX WITH REMARK 900 PKF049-365 REMARK 900 RELATED ID: 1KE5 RELATED DB: PDB REMARK 900 CDK2 COMPLEXED WITH N-METHYL-4-{[(2-OXO- 1,2-DIHYDRO-3H-INDOL-3- REMARK 900 YLIDENE)METHYL] AMINO}BENZENESULFONAMIDE REMARK 900 RELATED ID: 1KE6 RELATED DB: PDB REMARK 900 CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH N-METHYL-{4-[2-(7- REMARK 900 OXO-6,7-DIHYDRO -8H-[1,3]THIAZOLO[5,4-E]INDOL-8- YLIDENE)HYDRAZINO] REMARK 900 PHENYL}METHANESULFONAMIDE REMARK 900 RELATED ID: 1KE7 RELATED DB: PDB REMARK 900 CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH 3-{[(2,2-DIOXIDO-1, REMARK 900 3-DIHYDRO-2- BENZOTHIEN-5-YL)AMINO]METHYLENE}-5-(1,3- OXAZOL-5-YL)- REMARK 900 1,3-DIHYDRO-2H-INDOL-2- ONE REMARK 900 RELATED ID: 1KE8 RELATED DB: PDB REMARK 900 CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH 4-{[(2-OXO-1,2- REMARK 900 DIHYDRO-3H-INDOL-3 -YLIDENE)METHYL]AMINO}-N-(1,3-THIAZOL-2- YL) REMARK 900 BENZENESULFONAMIDE REMARK 900 RELATED ID: 1KE9 RELATED DB: PDB REMARK 900 CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH 3-{[4-({ REMARK 900 [AMINO(IMINO)METHYL] AMINOSULFONYL)ANILINO]METHYLENE}-2-OXO-2,3- REMARK 900 DIHYDRO-1H-INDOLE REMARK 900 RELATED ID: 1OGU RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/ CYCLIN A COMPLEXED WITH A 2- REMARK 900 ARYLAMINO-4- CYCLOHEXYLMETHYL-5-NITROSO-6-AMINOPYRIMIDINE INHIBITOR REMARK 900 RELATED ID: 1OI9 RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/ CYCLIN A COMPLEXED WITH A 6- REMARK 900 CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR REMARK 900 RELATED ID: 1OIQ RELATED DB: PDB REMARK 900 IMIDAZOPYRIDINES: A POTENT AND SELECTIVE CLASS OF CYCLIN-DEPENDENT REMARK 900 KINASE INHIBITORS IDENTIFIED THROUGH STRUCTURE-BASED HYBRIDISATION REMARK 900 RELATED ID: 1OIR RELATED DB: PDB REMARK 900 IMIDAZOPYRIDINES: A POTENT AND SELECTIVE CLASS OF CYCLIN-DEPENDENT REMARK 900 KINASE INHIBITORS IDENTIFIED THROUGH STRUCTURE-BASED HYBRIDISATION REMARK 900 RELATED ID: 1OIT RELATED DB: PDB REMARK 900 IMIDAZOPYRIDINES: A POTENT AND SELECTIVE CLASS OF CYCLIN-DEPENDENT REMARK 900 KINASE INHIBITORS IDENTIFIED THROUGH STRUCTURE-BASED HYBRIDISATION REMARK 900 RELATED ID: 1OIU RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/ CYCLIN A COMPLEXED WITH A 6- REMARK 900 CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR REMARK 900 RELATED ID: 1OIY RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/ CYCLIN A COMPLEXED WITH A 6- REMARK 900 CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR REMARK 900 RELATED ID: 1OKV RELATED DB: PDB REMARK 900 CYCLIN A BINDING GROOVE INHIBITOR H-ARG- ARG-LEU-ILE-PHE-NH2 REMARK 900 RELATED ID: 1OKW RELATED DB: PDB REMARK 900 CYCLIN A BINDING GROOVE INHIBITOR AC-ARG- ARG-LEU-ASN-(M-CL-PHE)-NH2 REMARK 900 RELATED ID: 1OL1 RELATED DB: PDB REMARK 900 CYCLIN A BINDING GROOVE INHIBITOR H-CIT- CIT-LEU-ILE-(P-F-PHE)-NH2 REMARK 900 RELATED ID: 1OL2 RELATED DB: PDB REMARK 900 CYCLIN A BINDING GROOVE INHIBITOR H-ARG- ARG-LEU-ASN-(P-F-PHE)-NH2 REMARK 900 RELATED ID: 1P2A RELATED DB: PDB REMARK 900 THE STRUCTURE OF CYCLIN DEPENDENT KINASE 2 (CKD2) WITH REMARK 900 ATRISUBSTITUTED NAPHTHOSTYRIL INHIBITOR REMARK 900 RELATED ID: 1P5E RELATED DB: PDB REMARK 900 THE STRUCURE OF PHOSPHO-CDK2/CYCLIN A IN COMPLEX WITH THEINHIBITOR REMARK 900 4,5,6,7- TETRABROMOBENZOTRIAZOLE (TBS) REMARK 900 RELATED ID: 1PF8 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLIN-DEPENDENT KINASE 2COMPLEXED WITH REMARK 900 A NUCLEOSIDE INHIBITOR REMARK 900 RELATED ID: 1PKD RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF UCN-01 IN COMPLEX WITH PHOSPHO-CDK2/CYCLIN REMARK 900 A REMARK 900 RELATED ID: 1PW2 RELATED DB: PDB REMARK 900 APO STRUCTURE OF HUMAN CYCLIN-DEPENDENT KINASE 2 REMARK 900 RELATED ID: 1PXI RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THEINHIBITOR 4-(2,5- REMARK 900 DICHLORO-THIOPHEN- 3-YL)-PYRIMIDIN-2-YLAMINE REMARK 900 RELATED ID: 1PXJ RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THEINHIBITOR 4-(2,4- REMARK 900 DIMETHYL-THIAZOL- 5-YL)-PYRIMIDIN-2-YLAMINE REMARK 900 RELATED ID: 1PXK RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THEINHIBITOR N-[4-(2, REMARK 900 4-DIMETHYL- THIAZOL-5-YL)PYRIMIDIN-2-YL]-N'- HYDROXYIMINOFORMAMIDE REMARK 900 RELATED ID: 1PXL RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THEINHIBITOR [4-(2,4- REMARK 900 DIMETHYL-THIAZOL- 5-YL)-PYRIMIDIN-2-YL]-(4-TRIFLUOROMETHYL- PHENYL)- REMARK 900 AMINE REMARK 900 RELATED ID: 1PXM RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THEINHIBITOR 3-[4-(2, REMARK 900 4-DIMETHYL- THIAZOL-5-YL)-PYRIMIDIN-2-YLAMINO]-PHENOL REMARK 900 RELATED ID: 1PXN RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THEINHIBITOR 4-[4-(4- REMARK 900 METHYL-2- METHYLAMINO-THIAZOL-5-YL)-PYRIMIDIN-2- YLAMINO]-PHENOL REMARK 900 RELATED ID: 1PXO RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THEINHIBITOR [4-(2- REMARK 900 AMINO-4-METHYL- THIAZOL-5-YL)-PYRIMIDIN-2-YL]-(3-NITRO- PHENYL)- REMARK 900 AMINE REMARK 900 RELATED ID: 1PXP RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THEINHIBITOR N-[4-(2, REMARK 900 4-DIMETHYL- THIAZOL-5-YL)-PYRIMIDIN-2-YL]-N',N'- DIMETHYL-BENZENE-1, REMARK 900 4-DIAMINE REMARK 900 RELATED ID: 1PYE RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CDK2 WITH INHIBITOR REMARK 900 RELATED ID: 1QMZ RELATED DB: PDB REMARK 900 PHOSPHORYLATED CDK2-CYCLYIN A-SUBSTRATE PEPTIDE COMPLEX REMARK 900 RELATED ID: 1R78 RELATED DB: PDB REMARK 900 CDK2 COMPLEX WITH A 4-ALKYNYL OXINDOLE INHIBITOR REMARK 900 RELATED ID: 1URC RELATED DB: PDB REMARK 900 CYCLIN A BINDING GROOVE INHIBITOR H-ARG- ARG-LEU-ASN-(P-F-PHE)-NH2 REMARK 900 RELATED ID: 1URW RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH AN IMIDAZO[1,2-B] PYRIDAZINE REMARK 900 RELATED ID: 1V1K RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH A DISUBSTITUTED 4, 6 -BIS ANILINO PYRIMIDINE REMARK 900 CDK4 INHIBITOR REMARK 900 RELATED ID: 1VYW RELATED DB: PDB REMARK 900 STRUCTURE OF CDK2/CYCLIN A WITH PNU-292137 REMARK 900 RELATED ID: 1VYZ RELATED DB: PDB REMARK 900 STRUCTURE OF CDK2 COMPLEXED WITH PNU-181227 REMARK 900 RELATED ID: 1W0X RELATED DB: PDB REMARK 900 CRYSTALS STRUCTURE OF HUMAN CDK2 IN COMPLEX WITH THE INHIBITOR REMARK 900 OLOMOUCINE. REMARK 900 RELATED ID: 1W8C RELATED DB: PDB REMARK 900 CO-CRYSTAL STRUCTURE OF 6-CYCLOHEXYLMETHOXY- 8-ISOPROPYL-9H-PURIN-2- REMARK 900 YLAMINE AND MONOMERIC CDK2 REMARK 900 RELATED ID: 1W98 RELATED DB: PDB REMARK 900 THE STRUCTURAL BASIS OF CDK2 ACTIVATION BY CYCLIN E REMARK 900 RELATED ID: 1WCC RELATED DB: PDB REMARK 900 SCREENING FOR FRAGMENT BINDING BY X-RAY CRYSTALLOGRAPHY REMARK 900 RELATED ID: 1Y8Y RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A PYRAZOLO[1,5-A] REMARK 900 PYRIMIDINE INHIBITOR REMARK 900 RELATED ID: 1Y91 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A PYRAZOLO[1,5-A] REMARK 900 PYRIMIDINE INHIBITOR REMARK 900 RELATED ID: 1YKR RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CDK2 WITH AN AMINOIMIDAZO PYRIDINEINHIBITOR REMARK 900 RELATED ID: 2A0C RELATED DB: PDB REMARK 900 HUMAN CDK2 IN COMPLEX WITH OLOMOUCINE II, A NOVEL 2,6,9- REMARK 900 TRISUBSTITUTED PURINE CYCLIN -DEPENDENT KINASE INHIBITOR REMARK 900 RELATED ID: 2B52 RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH DPH-042562 REMARK 900 RELATED ID: 2B53 RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH DIN-234325 REMARK 900 RELATED ID: 2B54 RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 (CKD2) COMPLEXED WITH DIN-232305 REMARK 900 RELATED ID: 2B55 RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2) COMPLEXED WITHINDENOPYRAXOLE REMARK 900 DIN-101312 REMARK 900 RELATED ID: 2BHE RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT PROTEIN KINASE 2 IN COMPLEX WITH THE REMARK 900 INHIBITOR 5-BROMO- INDIRUBINE REMARK 900 RELATED ID: 2BHH RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT PROTEIN KINASE 2 IN COMPLEX WITH THE REMARK 900 INHIBITOR 4- HYDROXYPIPERINDINESULFONYL-INDIRUBINE REMARK 900 RELATED ID: 2BKZ RELATED DB: PDB REMARK 900 STRUCTURE OF CDK2-CYCLIN A WITH PHA-404611 REMARK 900 RELATED ID: 2BPM RELATED DB: PDB REMARK 900 STRUCTURE OF CDK2-CYCLIN A WITH PHA-630529 REMARK 900 RELATED ID: 2BTR RELATED DB: PDB REMARK 900 STRUCTURE OF CDK2 COMPLEXED WITH PNU-198873 REMARK 900 RELATED ID: 2BTS RELATED DB: PDB REMARK 900 STRUCTURE OF CDK2 COMPLEXED WITH PNU-230032 REMARK 900 RELATED ID: 2C4G RELATED DB: PDB REMARK 900 STRUCTURE OF CDK2-CYCLIN A WITH PHA-533514 REMARK 900 RELATED ID: 2C5N RELATED DB: PDB REMARK 900 DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 REMARK 900 PROVIDES INSIGHTS FOR DRUG DESIGN REMARK 900 RELATED ID: 2C5O RELATED DB: PDB REMARK 900 DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 REMARK 900 PROVIDES INSIGHTS FOR DRUG DESIGN REMARK 900 RELATED ID: 2C5P RELATED DB: PDB REMARK 900 DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 REMARK 900 PROVIDES INSIGHTS FOR DRUG DESIGN REMARK 900 RELATED ID: 2C5T RELATED DB: PDB REMARK 900 DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 REMARK 900 PROVIDES INSIGHTS FOR DRUG DESIGN REMARK 900 RELATED ID: 2C5V RELATED DB: PDB REMARK 900 DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 REMARK 900 PROVIDES INSIGHTS FOR DRUG DESIGN REMARK 900 RELATED ID: 2C5X RELATED DB: PDB REMARK 900 DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 REMARK 900 PROVIDES INSIGHTS FOR DRUG DESIGN REMARK 900 RELATED ID: 2C5Y RELATED DB: PDB REMARK 900 DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 REMARK 900 PROVIDES INSIGHTS FOR DRUG DESIGN REMARK 900 RELATED ID: 2C68 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE REMARK 900 TRIAZOLOPYRIMIDINE INHIBITOR REMARK 900 RELATED ID: 2C69 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE REMARK 900 TRIAZOLOPYRIMIDINE INHIBITOR REMARK 900 RELATED ID: 2C6I RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE REMARK 900 TRIAZOLOPYRIMIDINE INHIBITOR REMARK 900 RELATED ID: 2C6K RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE REMARK 900 TRIAZOLOPYRIMIDINE INHIBITOR REMARK 900 RELATED ID: 2C6L RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE REMARK 900 TRIAZOLOPYRIMIDINE INHIBITOR REMARK 900 RELATED ID: 2C6M RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE REMARK 900 TRIAZOLOPYRIMIDINE INHIBITOR REMARK 900 RELATED ID: 2C6O RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE REMARK 900 TRIAZOLOPYRIMIDINE INHIBITOR REMARK 900 RELATED ID: 2C6T RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE REMARK 900 TRIAZOLOPYRIMIDINE INHIBITOR REMARK 900 RELATED ID: 2CCH RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF CDK2 CYCLIN A IN COMPLEX WITH A SUBSTRATE REMARK 900 PEPTIDE DERIVED FROM CDC MODIFIED WITH A GAMMA-LINKED ATP ANALOGUE REMARK 900 RELATED ID: 2CCI RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PHOSPHO-CDK2 CYCLIN A IN COMPLEX WITH A REMARK 900 PEPTIDE CONTAINING BOTH THE SUBSTRATE AND RECRUITMENT SITES OF CDC6 REMARK 900 RELATED ID: 2CJM RELATED DB: PDB REMARK 900 MECHANISM OF CDK INHIBITION BY ACTIVE SITE PHOSPHORYLATION: CDK2 REMARK 900 Y15P T160P IN COMPLEX WITH CYCLIN A STRUCTURE REMARK 900 RELATED ID: 2CLX RELATED DB: PDB REMARK 900 4-ARYLAZO-3,5-DIAMINO-1H-PYRAZOLE CDK INHIBITORS: SAR STUDY, REMARK 900 CRYSTAL STRUCTURE IN COMPLEX WITH CDK2, SELECTIVITY, AND CELLULAR REMARK 900 EFFECTS REMARK 900 RELATED ID: 2EXM RELATED DB: PDB REMARK 900 HUMAN CDK2 IN COMPLEX WITH ISOPENTENYLADENINE REMARK 900 RELATED ID: 2IW8 RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN THR160-PHOSPHO CDK2- CYCLIN A F82H-L83V-H84D REMARK 900 MUTANT WITH AN O6-CYCLOHEXYLMETHYLGUANINE INHIBITOR REMARK 900 RELATED ID: 2IW9 RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN THR160-PHOSPHO CDK2- CYCLIN A COMPLEXED WITH A REMARK 900 BISANILINOPYRIMIDINE INHIBITOR REMARK 999 REMARK 999 SEQUENCE REMARK 999 GPGS INTRODUCED AT N-TERMINUS BY CLONING. REMARK 999 M INTRODUCED AT N-TERMINUS BY CLONING. DBREF 2IW6 A 1 298 UNP P24941 CDK2_HUMAN 1 298 DBREF 2IW6 B 174 432 UNP P20248 CCNA2_HUMAN 174 432 DBREF 2IW6 C 1 298 UNP P24941 CDK2_HUMAN 1 298 DBREF 2IW6 D 174 432 UNP P20248 CCNA2_HUMAN 174 432 SEQADV 2IW6 GLY A -3 UNP P24941 EXPRESSION TAG SEQADV 2IW6 PRO A -2 UNP P24941 EXPRESSION TAG SEQADV 2IW6 GLY A -1 UNP P24941 EXPRESSION TAG SEQADV 2IW6 SER A 0 UNP P24941 EXPRESSION TAG SEQADV 2IW6 THR A 89 UNP P24941 LYS 89 ENGINEERED MUTATION SEQADV 2IW6 MET B 173 UNP P20248 EXPRESSION TAG SEQADV 2IW6 GLY C -3 UNP P24941 EXPRESSION TAG SEQADV 2IW6 PRO C -2 UNP P24941 EXPRESSION TAG SEQADV 2IW6 GLY C -1 UNP P24941 EXPRESSION TAG SEQADV 2IW6 SER C 0 UNP P24941 EXPRESSION TAG SEQADV 2IW6 THR C 89 UNP P24941 LYS 89 ENGINEERED MUTATION SEQADV 2IW6 MET D 173 UNP P20248 EXPRESSION TAG SEQRES 1 A 302 GLY PRO GLY SER MET GLU ASN PHE GLN LYS VAL GLU LYS SEQRES 2 A 302 ILE GLY GLU GLY THR TYR GLY VAL VAL TYR LYS ALA ARG SEQRES 3 A 302 ASN LYS LEU THR GLY GLU VAL VAL ALA LEU LYS LYS ILE SEQRES 4 A 302 ARG LEU ASP THR GLU THR GLU GLY VAL PRO SER THR ALA SEQRES 5 A 302 ILE ARG GLU ILE SER LEU LEU LYS GLU LEU ASN HIS PRO SEQRES 6 A 302 ASN ILE VAL LYS LEU LEU ASP VAL ILE HIS THR GLU ASN SEQRES 7 A 302 LYS LEU TYR LEU VAL PHE GLU PHE LEU HIS GLN ASP LEU SEQRES 8 A 302 LYS THR PHE MET ASP ALA SER ALA LEU THR GLY ILE PRO SEQRES 9 A 302 LEU PRO LEU ILE LYS SER TYR LEU PHE GLN LEU LEU GLN SEQRES 10 A 302 GLY LEU ALA PHE CYS HIS SER HIS ARG VAL LEU HIS ARG SEQRES 11 A 302 ASP LEU LYS PRO GLN ASN LEU LEU ILE ASN THR GLU GLY SEQRES 12 A 302 ALA ILE LYS LEU ALA ASP PHE GLY LEU ALA ARG ALA PHE SEQRES 13 A 302 GLY VAL PRO VAL ARG THR TYR TPO HIS GLU VAL VAL THR SEQRES 14 A 302 LEU TRP TYR ARG ALA PRO GLU ILE LEU LEU GLY CYS LYS SEQRES 15 A 302 TYR TYR SER THR ALA VAL ASP ILE TRP SER LEU GLY CYS SEQRES 16 A 302 ILE PHE ALA GLU MET VAL THR ARG ARG ALA LEU PHE PRO SEQRES 17 A 302 GLY ASP SER GLU ILE ASP GLN LEU PHE ARG ILE PHE ARG SEQRES 18 A 302 THR LEU GLY THR PRO ASP GLU VAL VAL TRP PRO GLY VAL SEQRES 19 A 302 THR SER MET PRO ASP TYR LYS PRO SER PHE PRO LYS TRP SEQRES 20 A 302 ALA ARG GLN ASP PHE SER LYS VAL VAL PRO PRO LEU ASP SEQRES 21 A 302 GLU ASP GLY ARG SER LEU LEU SER GLN MET LEU HIS TYR SEQRES 22 A 302 ASP PRO ASN LYS ARG ILE SER ALA LYS ALA ALA LEU ALA SEQRES 23 A 302 HIS PRO PHE PHE GLN ASP VAL THR LYS PRO VAL PRO HIS SEQRES 24 A 302 LEU ARG LEU SEQRES 1 B 260 MET GLU VAL PRO ASP TYR HIS GLU ASP ILE HIS THR TYR SEQRES 2 B 260 LEU ARG GLU MET GLU VAL LYS CYS LYS PRO LYS VAL GLY SEQRES 3 B 260 TYR MET LYS LYS GLN PRO ASP ILE THR ASN SER MET ARG SEQRES 4 B 260 ALA ILE LEU VAL ASP TRP LEU VAL GLU VAL GLY GLU GLU SEQRES 5 B 260 TYR LYS LEU GLN ASN GLU THR LEU HIS LEU ALA VAL ASN SEQRES 6 B 260 TYR ILE ASP ARG PHE LEU SER SER MET SER VAL LEU ARG SEQRES 7 B 260 GLY LYS LEU GLN LEU VAL GLY THR ALA ALA MET LEU LEU SEQRES 8 B 260 ALA SER LYS PHE GLU GLU ILE TYR PRO PRO GLU VAL ALA SEQRES 9 B 260 GLU PHE VAL TYR ILE THR ASP ASP THR TYR THR LYS LYS SEQRES 10 B 260 GLN VAL LEU ARG MET GLU HIS LEU VAL LEU LYS VAL LEU SEQRES 11 B 260 THR PHE ASP LEU ALA ALA PRO THR VAL ASN GLN PHE LEU SEQRES 12 B 260 THR GLN TYR PHE LEU HIS GLN GLN PRO ALA ASN CYS LYS SEQRES 13 B 260 VAL GLU SER LEU ALA MET PHE LEU GLY GLU LEU SER LEU SEQRES 14 B 260 ILE ASP ALA ASP PRO TYR LEU LYS TYR LEU PRO SER VAL SEQRES 15 B 260 ILE ALA GLY ALA ALA PHE HIS LEU ALA LEU TYR THR VAL SEQRES 16 B 260 THR GLY GLN SER TRP PRO GLU SER LEU ILE ARG LYS THR SEQRES 17 B 260 GLY TYR THR LEU GLU SER LEU LYS PRO CYS LEU MET ASP SEQRES 18 B 260 LEU HIS GLN THR TYR LEU LYS ALA PRO GLN HIS ALA GLN SEQRES 19 B 260 GLN SER ILE ARG GLU LYS TYR LYS ASN SER LYS TYR HIS SEQRES 20 B 260 GLY VAL SER LEU LEU ASN PRO PRO GLU THR LEU ASN LEU SEQRES 1 C 302 GLY PRO GLY SER MET GLU ASN PHE GLN LYS VAL GLU LYS SEQRES 2 C 302 ILE GLY GLU GLY THR TYR GLY VAL VAL TYR LYS ALA ARG SEQRES 3 C 302 ASN LYS LEU THR GLY GLU VAL VAL ALA LEU LYS LYS ILE SEQRES 4 C 302 ARG LEU ASP THR GLU THR GLU GLY VAL PRO SER THR ALA SEQRES 5 C 302 ILE ARG GLU ILE SER LEU LEU LYS GLU LEU ASN HIS PRO SEQRES 6 C 302 ASN ILE VAL LYS LEU LEU ASP VAL ILE HIS THR GLU ASN SEQRES 7 C 302 LYS LEU TYR LEU VAL PHE GLU PHE LEU HIS GLN ASP LEU SEQRES 8 C 302 LYS THR PHE MET ASP ALA SER ALA LEU THR GLY ILE PRO SEQRES 9 C 302 LEU PRO LEU ILE LYS SER TYR LEU PHE GLN LEU LEU GLN SEQRES 10 C 302 GLY LEU ALA PHE CYS HIS SER HIS ARG VAL LEU HIS ARG SEQRES 11 C 302 ASP LEU LYS PRO GLN ASN LEU LEU ILE ASN THR GLU GLY SEQRES 12 C 302 ALA ILE LYS LEU ALA ASP PHE GLY LEU ALA ARG ALA PHE SEQRES 13 C 302 GLY VAL PRO VAL ARG THR TYR TPO HIS GLU VAL VAL THR SEQRES 14 C 302 LEU TRP TYR ARG ALA PRO GLU ILE LEU LEU GLY CYS LYS SEQRES 15 C 302 TYR TYR SER THR ALA VAL ASP ILE TRP SER LEU GLY CYS SEQRES 16 C 302 ILE PHE ALA GLU MET VAL THR ARG ARG ALA LEU PHE PRO SEQRES 17 C 302 GLY ASP SER GLU ILE ASP GLN LEU PHE ARG ILE PHE ARG SEQRES 18 C 302 THR LEU GLY THR PRO ASP GLU VAL VAL TRP PRO GLY VAL SEQRES 19 C 302 THR SER MET PRO ASP TYR LYS PRO SER PHE PRO LYS TRP SEQRES 20 C 302 ALA ARG GLN ASP PHE SER LYS VAL VAL PRO PRO LEU ASP SEQRES 21 C 302 GLU ASP GLY ARG SER LEU LEU SER GLN MET LEU HIS TYR SEQRES 22 C 302 ASP PRO ASN LYS ARG ILE SER ALA LYS ALA ALA LEU ALA SEQRES 23 C 302 HIS PRO PHE PHE GLN ASP VAL THR LYS PRO VAL PRO HIS SEQRES 24 C 302 LEU ARG LEU SEQRES 1 D 260 MET GLU VAL PRO ASP TYR HIS GLU ASP ILE HIS THR TYR SEQRES 2 D 260 LEU ARG GLU MET GLU VAL LYS CYS LYS PRO LYS VAL GLY SEQRES 3 D 260 TYR MET LYS LYS GLN PRO ASP ILE THR ASN SER MET ARG SEQRES 4 D 260 ALA ILE LEU VAL ASP TRP LEU VAL GLU VAL GLY GLU GLU SEQRES 5 D 260 TYR LYS LEU GLN ASN GLU THR LEU HIS LEU ALA VAL ASN SEQRES 6 D 260 TYR ILE ASP ARG PHE LEU SER SER MET SER VAL LEU ARG SEQRES 7 D 260 GLY LYS LEU GLN LEU VAL GLY THR ALA ALA MET LEU LEU SEQRES 8 D 260 ALA SER LYS PHE GLU GLU ILE TYR PRO PRO GLU VAL ALA SEQRES 9 D 260 GLU PHE VAL TYR ILE THR ASP ASP THR TYR THR LYS LYS SEQRES 10 D 260 GLN VAL LEU ARG MET GLU HIS LEU VAL LEU LYS VAL LEU SEQRES 11 D 260 THR PHE ASP LEU ALA ALA PRO THR VAL ASN GLN PHE LEU SEQRES 12 D 260 THR GLN TYR PHE LEU HIS GLN GLN PRO ALA ASN CYS LYS SEQRES 13 D 260 VAL GLU SER LEU ALA MET PHE LEU GLY GLU LEU SER LEU SEQRES 14 D 260 ILE ASP ALA ASP PRO TYR LEU LYS TYR LEU PRO SER VAL SEQRES 15 D 260 ILE ALA GLY ALA ALA PHE HIS LEU ALA LEU TYR THR VAL SEQRES 16 D 260 THR GLY GLN SER TRP PRO GLU SER LEU ILE ARG LYS THR SEQRES 17 D 260 GLY TYR THR LEU GLU SER LEU LYS PRO CYS LEU MET ASP SEQRES 18 D 260 LEU HIS GLN THR TYR LEU LYS ALA PRO GLN HIS ALA GLN SEQRES 19 D 260 GLN SER ILE ARG GLU LYS TYR LYS ASN SER LYS TYR HIS SEQRES 20 D 260 GLY VAL SER LEU LEU ASN PRO PRO GLU THR LEU ASN LEU MODRES 2IW6 TPO A 160 THR PHOSPHOTHREONINE MODRES 2IW6 TPO C 160 THR PHOSPHOTHREONINE HET TPO A 160 11 HET TPO C 160 11 HET QQ2 A1296 33 HET SGM B1433 6 HET MG B1434 1 HET QQ2 C1296 33 HET SGM D1433 6 HETNAM TPO PHOSPHOTHREONINE HETNAM QQ2 [(2-CHLORO-5-METHYLPHENYL){6-[(4-{[(2R)-3- HETNAM 2 QQ2 (DIMETHYLAMINO)-2-HYDROXYPROPYL]OXY}PHENYL) HETNAM 3 QQ2 AMINO]PYRIMIDIN-4-YL}AMINO]ACETONITRILE HETNAM SGM MONOTHIOGLYCEROL HETNAM MG MAGNESIUM ION HETSYN TPO PHOSPHONOTHREONINE FORMUL 1 TPO 2(C4 H10 N O6 P) FORMUL 5 QQ2 2(C24 H27 CL N6 O2) FORMUL 6 SGM 2(C3 H8 O2 S) FORMUL 7 MG MG 2+ FORMUL 10 HOH *114(H2 O) HELIX 1 1 PRO A 45 LEU A 58 1 14 HELIX 2 2 LEU A 87 SER A 94 1 8 HELIX 3 3 PRO A 100 HIS A 121 1 22 HELIX 4 4 THR A 165 ARG A 169 5 5 HELIX 5 5 ALA A 170 LEU A 175 1 6 HELIX 6 6 THR A 182 ARG A 199 1 18 HELIX 7 7 SER A 207 GLY A 220 1 14 HELIX 8 8 GLY A 229 MET A 233 5 5 HELIX 9 9 ASP A 247 VAL A 252 1 6 HELIX 10 10 ASP A 256 LEU A 267 1 12 HELIX 11 11 SER A 276 LEU A 281 1 6 HELIX 12 12 ALA A 282 GLN A 287 5 6 HELIX 13 13 TYR B 178 CYS B 193 1 16 HELIX 14 14 GLY B 198 GLN B 203 1 6 HELIX 15 15 THR B 207 LYS B 226 1 20 HELIX 16 16 GLN B 228 LEU B 243 1 16 HELIX 17 17 LEU B 249 GLY B 251 5 3 HELIX 18 18 LYS B 252 GLU B 269 1 18 HELIX 19 19 GLU B 274 THR B 282 1 9 HELIX 20 20 THR B 287 LEU B 302 1 16 HELIX 21 21 THR B 310 LEU B 320 1 11 HELIX 22 22 ASN B 326 SER B 340 1 15 HELIX 23 23 ASP B 343 LEU B 348 1 6 HELIX 24 24 LEU B 351 GLY B 369 1 19 HELIX 25 25 PRO B 373 GLY B 381 1 9 HELIX 26 26 THR B 383 ALA B 401 1 19 HELIX 27 27 PRO B 402 HIS B 404 5 3 HELIX 28 28 GLN B 407 TYR B 413 1 7 HELIX 29 29 LYS B 414 HIS B 419 5 6 HELIX 30 30 GLY B 420 LEU B 424 5 5 HELIX 31 31 PRO C 45 LEU C 58 1 14 HELIX 32 32 LEU C 87 SER C 94 1 8 HELIX 33 33 PRO C 100 HIS C 121 1 22 HELIX 34 34 ASP C 145 ALA C 149 5 5 HELIX 35 35 THR C 165 ARG C 169 5 5 HELIX 36 36 ALA C 170 GLY C 176 1 7 HELIX 37 37 THR C 182 ARG C 199 1 18 HELIX 38 38 SER C 207 GLY C 220 1 14 HELIX 39 39 ASP C 247 VAL C 251 5 5 HELIX 40 40 ASP C 256 LEU C 267 1 12 HELIX 41 41 SER C 276 LEU C 281 1 6 HELIX 42 42 HIS C 283 GLN C 287 5 5 HELIX 43 43 TYR D 178 CYS D 193 1 16 HELIX 44 44 GLY D 198 GLN D 203 1 6 HELIX 45 45 THR D 207 TYR D 225 1 19 HELIX 46 46 GLN D 228 MET D 246 1 19 HELIX 47 47 LYS D 252 GLU D 269 1 18 HELIX 48 48 GLU D 274 ILE D 281 1 8 HELIX 49 49 THR D 287 LEU D 302 1 16 HELIX 50 50 THR D 310 PHE D 319 1 10 HELIX 51 51 LEU D 320 GLN D 322 5 3 HELIX 52 52 ASN D 326 SER D 340 1 15 HELIX 53 53 ASP D 343 LEU D 348 1 6 HELIX 54 54 LEU D 351 VAL D 367 1 17 HELIX 55 55 GLU D 374 GLY D 381 1 8 HELIX 56 56 THR D 383 ALA D 401 1 19 HELIX 57 57 PRO D 402 HIS D 404 5 3 HELIX 58 58 GLN D 407 TYR D 413 1 7 HELIX 59 59 ASN D 415 HIS D 419 5 5 SHEET 1 AA 5 PHE A 4 GLU A 12 0 SHEET 2 AA 5 VAL A 17 ASN A 23 -1 O VAL A 18 N ILE A 10 SHEET 3 AA 5 VAL A 29 ARG A 36 -1 O VAL A 30 N ALA A 21 SHEET 4 AA 5 LYS A 75 GLU A 81 -1 O LEU A 76 N ILE A 35 SHEET 5 AA 5 LEU A 66 HIS A 71 -1 N LEU A 67 O VAL A 79 SHEET 1 AB 3 GLN A 85 ASP A 86 0 SHEET 2 AB 3 LEU A 133 ILE A 135 -1 O ILE A 135 N GLN A 85 SHEET 3 AB 3 ILE A 141 LEU A 143 -1 O LYS A 142 N LEU A 134 SHEET 1 AC 2 VAL A 123 LEU A 124 0 SHEET 2 AC 2 ARG A 150 ALA A 151 -1 O ARG A 150 N LEU A 124 SHEET 1 CA 5 PHE C 4 GLU C 12 0 SHEET 2 CA 5 VAL C 17 ASN C 23 -1 O VAL C 18 N ILE C 10 SHEET 3 CA 5 VAL C 29 ARG C 36 -1 O VAL C 30 N ALA C 21 SHEET 4 CA 5 LYS C 75 GLU C 81 -1 O LEU C 76 N ILE C 35 SHEET 5 CA 5 LEU C 66 HIS C 71 -1 N LEU C 67 O VAL C 79 SHEET 1 CB 3 GLN C 85 ASP C 86 0 SHEET 2 CB 3 LEU C 133 ILE C 135 -1 O ILE C 135 N GLN C 85 SHEET 3 CB 3 ILE C 141 LEU C 143 -1 O LYS C 142 N LEU C 134 SHEET 1 CC 2 VAL C 123 LEU C 124 0 SHEET 2 CC 2 ARG C 150 ALA C 151 -1 O ARG C 150 N LEU C 124 LINK C TYR A 159 N TPO A 160 1555 1555 1.33 LINK C TPO A 160 N HIS A 161 1555 1555 1.33 LINK SG CYS B 193 S1 SGM B1433 1555 1555 2.01 LINK C TYR C 159 N TPO C 160 1555 1555 1.33 LINK C TPO C 160 N HIS C 161 1555 1555 1.34 LINK O MET B 200 MG MG B1434 1555 1555 2.58 LINK O GLN B 203 MG MG B1434 1555 1555 2.46 LINK O ILE B 206 MG MG B1434 1555 1555 2.64 CISPEP 1 VAL A 154 PRO A 155 0 -5.53 CISPEP 2 GLN B 323 PRO B 324 0 -3.03 CISPEP 3 ASP B 345 PRO B 346 0 10.46 CISPEP 4 VAL C 154 PRO C 155 0 0.12 CISPEP 5 GLN D 323 PRO D 324 0 -10.16 CISPEP 6 ASP D 345 PRO D 346 0 9.41 SITE 1 AC1 3 MET B 200 GLN B 203 ILE B 206 SITE 1 AC2 12 GLY A 11 GLU A 12 VAL A 18 ALA A 31 SITE 2 AC2 12 GLU A 81 LEU A 83 HIS A 84 ASP A 86 SITE 3 AC2 12 LEU A 134 ALA A 144 ASP A 145 HOH A2006 SITE 1 AC3 14 ILE C 10 GLU C 12 VAL C 18 ALA C 31 SITE 2 AC3 14 GLU C 81 PHE C 82 LEU C 83 HIS C 84 SITE 3 AC3 14 ASP C 86 GLN C 131 LEU C 134 ALA C 144 SITE 4 AC3 14 ASP C 145 HOH C2009 SITE 1 AC4 4 MET B 189 LYS B 192 CYS B 193 ARG B 241 SITE 1 AC5 5 MET D 189 LYS D 192 CYS D 193 ARG D 241 SITE 2 AC5 5 ASP D 305 CRYST1 73.777 134.557 148.265 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013554 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007432 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006745 0.00000 HETATM 1251 N TPO A 160 4.266 54.430 74.119 1.00 33.31 N HETATM 1252 CA TPO A 160 2.910 54.435 73.620 1.00 33.02 C HETATM 1253 CB TPO A 160 2.981 54.581 72.077 1.00 32.82 C HETATM 1254 CG2 TPO A 160 1.586 54.649 71.432 1.00 29.86 C HETATM 1255 OG1 TPO A 160 3.681 55.807 71.718 1.00 31.25 O HETATM 1256 P TPO A 160 5.111 55.917 71.048 1.00 31.67 P HETATM 1257 O1P TPO A 160 6.054 55.158 71.961 1.00 30.54 O HETATM 1258 O2P TPO A 160 5.022 55.280 69.707 1.00 32.39 O HETATM 1259 O3P TPO A 160 5.337 57.427 71.073 1.00 32.44 O HETATM 1260 C TPO A 160 2.198 53.190 74.053 1.00 34.91 C HETATM 1261 O TPO A 160 2.703 52.080 73.869 1.00 34.51 O TER 2355 HIS A 295 TER 4432 LEU B 432 HETATM 5707 N TPO C 160 48.464 68.310 30.929 1.00 34.54 N HETATM 5708 CA TPO C 160 47.942 69.219 29.901 1.00 35.21 C HETATM 5709 CB TPO C 160 46.493 69.573 30.245 1.00 34.63 C HETATM 5710 CG2 TPO C 160 45.840 70.380 29.126 1.00 34.06 C HETATM 5711 OG1 TPO C 160 45.712 68.379 30.444 1.00 33.88 O HETATM 5712 P TPO C 160 45.214 67.793 31.881 1.00 31.88 P HETATM 5713 O1P TPO C 160 46.444 67.665 32.735 1.00 32.73 O HETATM 5714 O2P TPO C 160 44.214 68.796 32.410 1.00 31.84 O HETATM 5715 O3P TPO C 160 44.623 66.457 31.496 1.00 32.51 O HETATM 5716 C TPO C 160 48.806 70.456 29.783 1.00 36.55 C HETATM 5717 O TPO C 160 49.215 71.014 30.810 1.00 36.42 O TER 6811 HIS C 295 TER 8873 LEU D 432 HETATM 8874 C22 QQ2 A1296 3.868 41.776 50.557 1.00 44.59 C HETATM 8875 C1 QQ2 A1296 9.721 44.776 50.454 1.00 35.00 C HETATM 8876 C5 QQ2 A1296 7.754 43.670 49.894 1.00 39.68 C HETATM 8877 C4 QQ2 A1296 7.057 44.598 50.699 1.00 40.68 C HETATM 8878 C3 QQ2 A1296 7.742 45.625 51.384 1.00 39.68 C HETATM 8879 C11 QQ2 A1296 3.192 45.811 53.544 1.00 46.80 C HETATM 8880 C10 QQ2 A1296 3.434 46.478 52.348 1.00 47.31 C HETATM 8881 C9 QQ2 A1296 4.743 46.727 51.912 1.00 46.51 C HETATM 8882 C8 QQ2 A1296 5.838 46.291 52.665 1.00 46.52 C HETATM 8883 C12 QQ2 A1296 4.264 45.364 54.311 1.00 46.83 C HETATM 8884 C17 QQ2 A1296 8.643 47.655 53.811 1.00 49.07 C HETATM 8885 C16 QQ2 A1296 7.788 47.810 52.583 1.00 44.10 C HETATM 8886 C13 QQ2 A1296 5.560 45.602 53.867 1.00 46.64 C HETATM 8887 C20 QQ2 A1296 5.868 42.147 49.293 1.00 41.23 C HETATM 8888 N2 QQ2 A1296 9.081 45.670 51.226 1.00 38.30 N HETATM 8889 N6 QQ2 A1296 9.086 43.804 49.790 1.00 36.85 N HETATM 8890 N7 QQ2 A1296 7.115 46.545 52.197 1.00 43.66 N HETATM 8891 N18 QQ2 A1296 9.349 47.552 54.769 1.00 45.10 N HETATM 8892 N19 QQ2 A1296 7.149 42.607 49.172 1.00 42.61 N HETATM 8893 C21 QQ2 A1296 5.174 42.253 50.495 1.00 40.99 C HETATM 8894 C23 QQ2 A1296 3.229 41.196 49.455 1.00 45.09 C HETATM 8895 C24 QQ2 A1296 3.935 41.089 48.251 1.00 44.18 C HETATM 8896 C25 QQ2 A1296 5.257 41.568 48.195 1.00 41.62 C HETATM 8897 O26 QQ2 A1296 1.932 40.744 49.622 1.00 46.45 O HETATM 8898 C27 QQ2 A1296 1.129 40.212 48.562 1.00 50.68 C HETATM 8899 C28 QQ2 A1296 -0.402 40.196 48.801 1.00 52.01 C HETATM 8900 C29 QQ2 A1296 -0.906 40.649 50.190 1.00 53.91 C HETATM 8901 N30 QQ2 A1296 -2.404 40.594 50.223 1.00 56.00 N HETATM 8902 C31 QQ2 A1296 -3.175 41.746 50.699 1.00 55.50 C HETATM 8903 C32 QQ2 A1296 -3.162 39.369 49.953 1.00 54.66 C HETATM 8904 O33 QQ2 A1296 -1.028 40.979 47.766 1.00 53.30 O HETATM 8905 CL1 QQ2 A1296 6.836 44.978 54.925 1.00 49.60 CL HETATM 8906 C33 QQ2 A1296 2.277 46.950 51.519 1.00 45.90 C HETATM 8907 C1 SGM B1433 25.115 60.116 63.377 1.00 43.53 C HETATM 8908 C2 SGM B1433 24.981 58.934 62.402 1.00 45.90 C HETATM 8909 O2 SGM B1433 24.441 57.780 63.046 1.00 45.87 O HETATM 8910 C3 SGM B1433 26.293 58.466 61.772 1.00 48.39 C HETATM 8911 O3 SGM B1433 27.015 59.551 61.154 1.00 50.80 O HETATM 8912 S1 SGM B1433 23.909 60.163 64.777 1.00 42.85 S HETATM 8913 MG MG B1434 31.332 82.938 65.780 1.00 31.07 MG HETATM 8914 C22 QQ2 C1296 34.600 87.705 42.953 1.00 41.45 C HETATM 8915 C1 QQ2 C1296 33.388 82.243 46.227 1.00 40.22 C HETATM 8916 C5 QQ2 C1296 33.296 84.388 45.344 1.00 40.60 C HETATM 8917 C4 QQ2 C1296 33.509 83.870 44.053 1.00 40.86 C HETATM 8918 C3 QQ2 C1296 33.657 82.485 43.914 1.00 41.46 C HETATM 8919 C11 QQ2 C1296 35.505 83.798 39.357 1.00 47.73 C HETATM 8920 C10 QQ2 C1296 34.132 83.758 39.592 1.00 48.92 C HETATM 8921 C9 QQ2 C1296 33.616 83.112 40.720 1.00 48.73 C HETATM 8922 C8 QQ2 C1296 34.458 82.483 41.645 1.00 47.09 C HETATM 8923 C12 QQ2 C1296 36.360 83.187 40.258 1.00 48.43 C HETATM 8924 C17 QQ2 C1296 34.702 79.527 43.138 1.00 45.49 C HETATM 8925 C16 QQ2 C1296 33.590 80.404 42.676 1.00 45.79 C HETATM 8926 C13 QQ2 C1296 35.841 82.533 41.387 1.00 49.55 C HETATM 8927 C20 QQ2 C1296 33.384 86.757 44.779 1.00 41.14 C HETATM 8928 N2 QQ2 C1296 33.572 81.717 45.018 1.00 40.11 N HETATM 8929 N6 QQ2 C1296 33.243 83.555 46.392 1.00 40.12 N HETATM 8930 N7 QQ2 C1296 33.914 81.845 42.740 1.00 44.26 N HETATM 8931 N18 QQ2 C1296 35.526 78.737 43.407 1.00 43.82 N HETATM 8932 N19 QQ2 C1296 33.136 85.748 45.643 1.00 41.27 N HETATM 8933 C21 QQ2 C1296 34.390 86.651 43.819 1.00 40.20 C HETATM 8934 C23 QQ2 C1296 33.816 88.858 43.059 1.00 42.79 C HETATM 8935 C24 QQ2 C1296 32.817 88.975 44.026 1.00 40.90 C HETATM 8936 C25 QQ2 C1296 32.601 87.903 44.875 1.00 40.56 C HETATM 8937 O26 QQ2 C1296 34.046 89.898 42.204 1.00 43.44 O HETATM 8938 C27 QQ2 C1296 33.520 89.892 40.886 1.00 49.27 C HETATM 8939 C28 QQ2 C1296 34.567 90.593 40.041 1.00 51.38 C HETATM 8940 C29 QQ2 C1296 35.459 89.524 39.385 1.00 54.49 C HETATM 8941 N30 QQ2 C1296 35.066 89.191 38.016 1.00 56.06 N HETATM 8942 C31 QQ2 C1296 35.904 89.753 36.950 1.00 56.30 C HETATM 8943 C32 QQ2 C1296 34.402 87.910 37.782 1.00 53.97 C HETATM 8944 O33 QQ2 C1296 33.919 91.501 39.146 1.00 51.30 O HETATM 8945 CL1 QQ2 C1296 37.034 81.782 42.495 1.00 51.87 CL HETATM 8946 C33 QQ2 C1296 33.196 84.414 38.613 1.00 48.76 C HETATM 8947 C1 SGM D1433 36.367 57.372 48.894 1.00 54.93 C HETATM 8948 C2 SGM D1433 36.547 57.984 50.277 1.00 55.69 C HETATM 8949 O2 SGM D1433 35.233 58.065 50.839 1.00 56.51 O HETATM 8950 C3 SGM D1433 37.217 59.365 50.221 1.00 55.87 C HETATM 8951 O3 SGM D1433 36.439 60.333 50.943 1.00 55.92 O HETATM 8952 S1 SGM D1433 37.699 57.699 47.700 1.00 55.56 S HETATM 8953 O HOH A2001 16.640 60.043 38.277 1.00 44.35 O HETATM 8954 O HOH A2002 20.831 48.952 41.961 1.00 27.95 O HETATM 8955 O HOH A2003 17.742 50.792 43.183 1.00 35.75 O HETATM 8956 O HOH A2004 23.082 37.278 63.513 1.00 36.15 O HETATM 8957 O HOH A2005 3.484 61.575 66.446 1.00 35.30 O HETATM 8958 O HOH A2006 10.112 49.308 57.078 1.00 33.32 O HETATM 8959 O HOH A2007 20.123 57.549 63.392 1.00 29.13 O HETATM 8960 O HOH A2008 19.342 45.361 56.722 1.00 21.88 O HETATM 8961 O HOH A2009 18.801 59.830 46.859 1.00 46.91 O HETATM 8962 O HOH A2010 3.214 30.972 47.841 1.00 38.57 O HETATM 8963 O HOH A2011 4.118 31.106 82.691 1.00 26.41 O HETATM 8964 O HOH A2012 15.032 28.854 54.908 1.00 37.91 O HETATM 8965 O HOH A2013 21.321 38.403 65.737 1.00 30.05 O HETATM 8966 O HOH A2014 20.594 34.639 59.229 1.00 26.21 O HETATM 8967 O HOH A2015 22.564 40.063 69.816 1.00 27.05 O HETATM 8968 O HOH A2016 20.170 56.227 70.906 1.00 23.96 O HETATM 8969 O HOH A2017 1.774 43.077 65.492 1.00 29.53 O HETATM 8970 O HOH A2018 2.216 41.968 53.401 1.00 42.49 O HETATM 8971 O HOH A2019 12.168 32.369 51.912 1.00 28.41 O HETATM 8972 O HOH A2020 18.944 42.511 54.599 1.00 21.02 O HETATM 8973 O HOH A2021 7.268 48.504 63.524 1.00 21.74 O HETATM 8974 O HOH A2022 6.910 54.599 65.534 1.00 31.76 O HETATM 8975 O HOH A2023 12.377 56.249 68.723 1.00 19.22 O HETATM 8976 O HOH A2024 15.088 55.436 79.533 1.00 33.07 O HETATM 8977 O HOH A2025 7.825 50.798 78.266 1.00 23.30 O HETATM 8978 O HOH A2026 13.614 55.775 77.244 1.00 25.35 O HETATM 8979 O HOH A2027 -0.204 56.218 74.877 1.00 29.21 O HETATM 8980 O HOH A2028 -5.182 45.573 66.127 1.00 30.28 O HETATM 8981 O HOH A2029 -2.169 35.180 67.713 1.00 18.23 O HETATM 8982 O HOH A2030 -1.618 37.685 71.456 1.00 28.43 O HETATM 8983 O HOH A2031 7.339 43.657 78.051 1.00 27.24 O HETATM 8984 O HOH A2032 2.777 49.245 85.567 1.00 42.38 O HETATM 8985 O HOH A2033 5.088 51.382 78.480 1.00 29.82 O HETATM 8986 O HOH A2034 14.015 40.156 75.444 1.00 16.46 O HETATM 8987 O HOH A2035 3.369 41.751 71.702 1.00 22.49 O HETATM 8988 O HOH A2036 5.750 42.917 68.071 1.00 16.36 O HETATM 8989 O HOH A2037 -0.613 33.710 66.045 1.00 20.67 O HETATM 8990 O HOH A2038 -12.139 44.987 75.816 1.00 29.52 O HETATM 8991 O HOH A2039 -0.523 30.116 84.194 1.00 25.99 O HETATM 8992 O HOH A2040 5.656 42.763 85.270 1.00 32.83 O HETATM 8993 O HOH A2041 -13.724 39.969 84.180 1.00 29.71 O HETATM 8994 O HOH A2042 -1.585 16.637 71.546 1.00 29.90 O HETATM 8995 O HOH A2043 12.392 16.957 69.455 1.00 34.28 O HETATM 8996 O HOH A2044 13.974 20.921 74.924 1.00 25.45 O HETATM 8997 O HOH A2045 2.729 31.010 79.742 1.00 28.47 O HETATM 8998 O HOH A2046 11.933 38.271 76.131 1.00 20.79 O HETATM 8999 O HOH A2047 20.686 24.161 69.219 1.00 31.95 O HETATM 9000 O HOH A2048 19.275 34.090 51.206 1.00 30.91 O HETATM 9001 O HOH B2001 35.179 57.022 73.100 1.00 24.69 O HETATM 9002 O HOH B2002 28.111 64.797 71.633 1.00 37.32 O HETATM 9003 O HOH B2003 15.823 55.929 84.873 1.00 29.23 O HETATM 9004 O HOH B2004 25.034 77.262 84.828 1.00 22.89 O HETATM 9005 O HOH B2005 19.814 38.487 76.804 1.00 40.75 O HETATM 9006 O HOH B2006 14.818 39.635 72.974 1.00 22.79 O HETATM 9007 O HOH B2007 24.266 42.285 76.357 1.00 30.59 O HETATM 9008 O HOH B2008 30.366 54.774 79.265 1.00 24.23 O HETATM 9009 O HOH B2009 30.172 48.296 76.756 1.00 28.14 O HETATM 9010 O HOH B2010 27.975 62.575 70.571 1.00 23.52 O HETATM 9011 O HOH B2011 32.437 56.402 73.217 1.00 27.32 O HETATM 9012 O HOH B2012 27.179 87.359 71.420 1.00 32.96 O HETATM 9013 O HOH B2013 26.800 77.980 74.158 1.00 28.44 O HETATM 9014 O HOH B2014 30.053 84.322 73.335 1.00 46.44 O HETATM 9015 O HOH B2015 16.649 82.126 76.887 1.00 40.94 O HETATM 9016 O HOH B2016 19.898 77.297 82.277 1.00 26.20 O HETATM 9017 O HOH B2017 16.334 58.617 72.394 1.00 19.79 O HETATM 9018 O HOH B2018 25.954 68.976 71.395 1.00 30.31 O HETATM 9019 O HOH B2019 26.805 82.405 61.992 1.00 33.28 O HETATM 9020 O HOH B2020 6.008 61.009 68.506 1.00 32.90 O HETATM 9021 O HOH B2021 6.680 64.003 77.800 1.00 18.92 O HETATM 9022 O HOH B2022 10.794 87.716 61.938 1.00 41.50 O HETATM 9023 O HOH B2023 11.544 79.964 53.217 1.00 31.82 O HETATM 9024 O HOH B2024 8.515 69.372 57.011 1.00 30.67 O HETATM 9025 O HOH B2025 15.942 71.115 52.118 1.00 35.50 O HETATM 9026 O HOH B2026 20.163 56.452 61.181 1.00 36.64 O HETATM 9027 O HOH B2027 18.133 58.292 70.420 1.00 19.53 O HETATM 9028 O HOH B2028 25.631 61.651 70.229 1.00 25.54 O HETATM 9029 O HOH B2029 24.367 64.035 72.362 1.00 31.29 O HETATM 9030 O HOH B2030 23.218 64.994 75.757 1.00 28.68 O HETATM 9031 O HOH B2031 17.969 54.634 85.769 1.00 38.10 O HETATM 9032 O HOH B2032 23.587 49.264 79.891 1.00 34.44 O HETATM 9033 O HOH B2033 23.796 49.525 83.514 1.00 36.07 O HETATM 9034 O HOH B2034 26.431 68.606 76.875 1.00 26.40 O HETATM 9035 O HOH B2035 27.005 72.147 75.289 1.00 26.91 O HETATM 9036 O HOH B2036 25.223 76.443 82.229 1.00 27.91 O HETATM 9037 O HOH B2037 30.191 78.776 76.085 1.00 27.09 O HETATM 9038 O HOH B2038 28.971 67.833 74.600 1.00 30.15 O HETATM 9039 O HOH B2039 35.416 63.039 75.872 1.00 20.87 O HETATM 9040 O HOH B2040 30.524 48.964 92.620 1.00 30.42 O HETATM 9041 O HOH B2041 35.463 57.639 75.494 1.00 29.48 O HETATM 9042 O HOH B2042 38.424 55.625 89.766 1.00 38.87 O HETATM 9043 O HOH B2043 41.312 57.033 88.823 1.00 41.99 O HETATM 9044 O HOH B2044 37.178 63.906 81.264 1.00 31.52 O HETATM 9045 O HOH B2045 27.365 78.175 85.575 1.00 34.30 O HETATM 9046 O HOH B2046 22.555 72.156 93.772 1.00 32.85 O HETATM 9047 O HOH B2047 22.652 78.538 85.817 1.00 31.37 O HETATM 9048 O HOH B2048 20.195 77.385 84.908 1.00 25.46 O HETATM 9049 O HOH B2049 32.371 70.971 100.935 1.00 47.14 O HETATM 9050 O HOH C2001 28.359 76.500 55.976 1.00 32.24 O HETATM 9051 O HOH C2002 23.312 77.446 52.255 1.00 25.68 O HETATM 9052 O HOH C2003 18.607 62.352 27.497 1.00 50.42 O HETATM 9053 O HOH C2004 34.939 66.489 29.845 1.00 36.62 O HETATM 9054 O HOH C2005 38.809 65.887 29.083 1.00 39.90 O HETATM 9055 O HOH C2006 35.697 69.340 30.288 1.00 44.79 O HETATM 9056 O HOH C2007 33.665 87.935 52.840 1.00 47.29 O HETATM 9057 O HOH C2008 42.416 75.694 39.110 1.00 32.75 O HETATM 9058 O HOH C2009 32.786 88.779 35.508 1.00 48.04 O HETATM 9059 O HOH D2001 41.421 50.636 48.369 1.00 46.61 O HETATM 9060 O HOH D2002 26.733 36.666 44.144 1.00 29.51 O HETATM 9061 O HOH D2003 43.372 38.707 32.604 1.00 46.54 O HETATM 9062 O HOH D2004 49.519 55.067 34.542 1.00 43.21 O HETATM 9063 O HOH D2005 23.568 41.143 41.549 1.00 33.74 O HETATM 9064 O HOH D2006 32.213 42.813 29.462 1.00 38.83 O HETATM 9065 O HOH D2007 21.585 60.834 29.678 1.00 40.94 O HETATM 9066 O HOH D2008 19.142 61.384 30.294 1.00 50.94 O CONECT 1241 1251 CONECT 1251 1241 1252 CONECT 1252 1251 1253 1260 CONECT 1253 1252 1254 1255 CONECT 1254 1253 CONECT 1255 1253 1256 CONECT 1256 1255 1257 1258 1259 CONECT 1257 1256 CONECT 1258 1256 CONECT 1259 1256 CONECT 1260 1252 1261 1262 CONECT 1261 1260 CONECT 1262 1260 CONECT 2513 8912 CONECT 2565 8913 CONECT 2591 8913 CONECT 2615 8913 CONECT 5697 5707 CONECT 5707 5697 5708 CONECT 5708 5707 5709 5716 CONECT 5709 5708 5710 5711 CONECT 5710 5709 CONECT 5711 5709 5712 CONECT 5712 5711 5713 5714 5715 CONECT 5713 5712 CONECT 5714 5712 CONECT 5715 5712 CONECT 5716 5708 5717 5718 CONECT 5717 5716 CONECT 5718 5716 CONECT 8874 8893 8894 CONECT 8875 8888 8889 CONECT 8876 8877 8889 8892 CONECT 8877 8876 8878 CONECT 8878 8877 8888 8890 CONECT 8879 8880 8883 CONECT 8880 8879 8881 8906 CONECT 8881 8880 8882 CONECT 8882 8881 8886 8890 CONECT 8883 8879 8886 CONECT 8884 8885 8891 CONECT 8885 8884 8890 CONECT 8886 8882 8883 8905 CONECT 8887 8892 8893 8896 CONECT 8888 8875 8878 CONECT 8889 8875 8876 CONECT 8890 8878 8882 8885 CONECT 8891 8884 CONECT 8892 8876 8887 CONECT 8893 8874 8887 CONECT 8894 8874 8895 8897 CONECT 8895 8894 8896 CONECT 8896 8887 8895 CONECT 8897 8894 8898 CONECT 8898 8897 8899 CONECT 8899 8898 8900 8904 CONECT 8900 8899 8901 CONECT 8901 8900 8902 8903 CONECT 8902 8901 CONECT 8903 8901 CONECT 8904 8899 CONECT 8905 8886 CONECT 8906 8880 CONECT 8907 8908 8912 CONECT 8908 8907 8909 8910 CONECT 8909 8908 CONECT 8910 8908 8911 CONECT 8911 8910 CONECT 8912 2513 8907 CONECT 8913 2565 2591 2615 CONECT 8914 8933 8934 CONECT 8915 8928 8929 CONECT 8916 8917 8929 8932 CONECT 8917 8916 8918 CONECT 8918 8917 8928 8930 CONECT 8919 8920 8923 CONECT 8920 8919 8921 8946 CONECT 8921 8920 8922 CONECT 8922 8921 8926 8930 CONECT 8923 8919 8926 CONECT 8924 8925 8931 CONECT 8925 8924 8930 CONECT 8926 8922 8923 8945 CONECT 8927 8932 8933 8936 CONECT 8928 8915 8918 CONECT 8929 8915 8916 CONECT 8930 8918 8922 8925 CONECT 8931 8924 CONECT 8932 8916 8927 CONECT 8933 8914 8927 CONECT 8934 8914 8935 8937 CONECT 8935 8934 8936 CONECT 8936 8927 8935 CONECT 8937 8934 8938 CONECT 8938 8937 8939 CONECT 8939 8938 8940 8944 CONECT 8940 8939 8941 CONECT 8941 8940 8942 8943 CONECT 8942 8941 CONECT 8943 8941 CONECT 8944 8939 CONECT 8945 8926 CONECT 8946 8920 CONECT 8947 8948 8952 CONECT 8948 8947 8949 8950 CONECT 8949 8948 CONECT 8950 8948 8951 CONECT 8951 8950 CONECT 8952 8947 MASTER 855 0 7 59 20 0 11 6 9062 4 109 88 END